Business And Financial Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025 1 year ago admin Fulcrum Therapeutics, Inc. ― Announced results from the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of...